» Articles » PMID: 17176758

Inhibition of Mammalian Cathepsins by Plesiomonas Shigelloides

Overview
Publisher Springer
Specialty Microbiology
Date 2006 Dec 21
PMID 17176758
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

To study molecular mechanisms underlying self-defense of the bacterial pathogen Plesiomonas shigelloides against host inflammatory and immune responses, we evaluated its interactions with mammalian papain-like cathepsins that are essential for host immunity. When grown under anaerobic, but not aerobic, conditions, P. shigelloides was shown to bind and inhibit papain, a model representative of the papain family of cysteine proteinases. This points to mammalian cathepsins as likely physiological targets of a novel cysteine-proteinase inhibitor expressed on bacterial cell surface. Both papain and mammalian cathepsins L and B were inhibited by periplasmic extracts of aerobically and anaerobically grown bacteria, the inhibitory activity being higher in the latter. Inhibition by both intact cells and periplasmic samples was rapid and efficient. The results suggest a possible defensive role of bacterial inhibitors of cathepsins during invasion of a mammalian host. The bacteria thus may modulate host protective responses through inhibiting cathepsins involved in antigen processing and presentation.

Citing Articles

Microbial inhibitors of cysteine proteases.

Kedzior M, Seredynski R, Gutowicz J Med Microbiol Immunol. 2016; 205(4):275-96.

PMID: 27048482 DOI: 10.1007/s00430-016-0454-1.

References
1.
BJORK I, Pol E, Abrahamson M, Rowan A, Mort J . Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes. Biochem J. 1994; 299 ( Pt 1):219-25. PMC: 1138045. DOI: 10.1042/bj2990219. View

2.
Linebaugh B, Sameni M, Day N, Sloane B, Keppler D . Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem. 1999; 264(1):100-9. DOI: 10.1046/j.1432-1327.1999.00582.x. View

3.
Sanderson S, Westrop G, Scharfstein J, Mottram J, Coombs G . Functional conservation of a natural cysteine peptidase inhibitor in protozoan and bacterial pathogens. FEBS Lett. 2003; 542(1-3):12-6. DOI: 10.1016/s0014-5793(03)00327-2. View

4.
Beers C, Burich A, Kleijmeer M, Griffith J, Wong P, Rudensky A . Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J Immunol. 2005; 174(3):1205-12. DOI: 10.4049/jimmunol.174.3.1205. View

5.
Pavlova A, Krupa J, Mort J, Abrahamson M, BJORK I . Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110. FEBS Lett. 2001; 487(2):156-60. DOI: 10.1016/s0014-5793(00)02337-1. View